CrazyFruits - Live

everything under the sun


Latest topics
» Stunning afro nubian diamond chics
Mon 29 Jan 2018 - 18:27 by After8mint

» Stunning black and white pics of Nubian goddess
Mon 29 Jan 2018 - 18:20 by After8mint

» Your merry x mas season pics
Wed 13 Dec 2017 - 20:11 by After8mint

» Just a bunch of colours
Wed 13 Dec 2017 - 20:07 by After8mint

» Beautiful photo magic from artist
Wed 13 Dec 2017 - 20:01 by After8mint

» Put some colour in your art VG art
Wed 13 Dec 2017 - 19:55 by After8mint

» Lovely blk and white pics from your artists
Wed 13 Dec 2017 - 19:51 by After8mint

» Have yourself a merry little Christmas crazyfruiters!!!
Wed 13 Dec 2017 - 19:48 by After8mint

» How to keep feet warm in the winter
Wed 13 Dec 2017 - 19:42 by After8mint

» Why it's important to read
Wed 13 Dec 2017 - 13:57 by After8mint

» A lovely Christmas birthday or just plain gift for a love one
Wed 13 Dec 2017 - 13:48 by After8mint

» Artist pictures AF an artists
Wed 13 Dec 2017 - 13:45 by After8mint

» Beautiful pencil art from an artists
Wed 13 Dec 2017 - 13:41 by After8mint

» Colourful art of an artists
Wed 13 Dec 2017 - 13:38 by After8mint

» Poems Spring To Life
Thu 9 Nov 2017 - 5:11 by After8mint

» Jamaica Norman Manley Law School wins moot court competition
Fri 1 Sep 2017 - 15:23 by azealiabanks

» Very BLACK SNAKE DREAM!!
Fri 1 Sep 2017 - 15:23 by azealiabanks

» jUST CALL TO SAY HELL OO
Fri 1 Sep 2017 - 15:22 by azealiabanks

» US formally tells UN it wants out of Paris climate accord
Fri 1 Sep 2017 - 15:12 by IggyAzealia

» Iggy azalea here pls say hi
Fri 1 Sep 2017 - 15:11 by IggyAzealia

Search
 
 

Display results as :
 


Rechercher Advanced Search

Statistics
We have 10527 registered users
The newest registered user is SamanthaJ

Our users have posted a total of 13394 messages in 7480 subjects
Acute migraine drug succeeds in late-stage study

Sat 5 Aug 2017 - 10:51 by JustinBieber2

Eli Lilly and Co said on Friday said its acute migraine drug, lasmiditan, induced a statistically significant improvement in pain relief against a placebo in a late-stage study.

The trial tested three doses of the oral drug against a placebo. Patients in the trial had an average of more than five migraine attacks per month.

Lilly, which acquired lasmiditan through its $960 million purchase of CoLucid Pharmaceuticals in January, said it plans to file a U.S. marketing application for the drug in the second half of 2018.

About 40 million Americans suffer from migraines, and the disease costs the United States about $36 billion annually in healthcare and lost productivity, according to the Migraine Research Foundation.

Comments: 1

Who is online?
In total there is 1 user online :: 0 Registered, 0 Hidden and 1 Guest

None

Most users ever online was 3522 on Sat 11 Feb 2012 - 22:23
 Portal
 Index
 Memberlist
 Profile
 FAQ
 Search
 Portal
 Index
 Memberlist
 Profile
 FAQ
 Search
 Portal
 Index
 Memberlist
 Profile
 FAQ
 Search
Poll